Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 6, 2025

Kura Oncology to Participate in Bank of America Securities Healthcare Conference
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Bank of …

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
‒ Q1 2025 Net Revenue of $39.1mm; Adjusted EBITDA of $23.6mm ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, NJ., May 06, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on …

Genie Energy Announces First Quarter 2025 Results
Newark, NJ, May 06, 2025 (GLOBE NEWSWIRE) -- Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the first quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, …

Bioventus Reports First Quarter Financial Results
Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0% First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year period Non-GAAP earnings* of $0.08 per share increased 33% Company reiterated …

Sono Hits the Road: Confirmed Trade Show Appearances Across Europe in 2025
Munich, Germany, May 06, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) is pleased to announce its confirmed …

Neuronetics Reports First Quarter 2025 Financial and Operating Results
MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of …

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk …

Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
PRINCETON, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004
-- PAS-004 shows up to 91% inhibition of pERK, confirming substantial target engagement -- -- One patient in cohort 4A with stage 4 KRAS G12R mutated pancreatic cancer achieves over 5 months of stable disease with tumor volume reduction of -9.8% -- MIAMI, …

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer
Cost-saving initiatives expected to extend company’s cash runway and support current operating plan commitments into mid-2026 Company to host conference call at 8:00 a.m. ET on May 15 to discuss business updates and first quarter 2025 financial results …

ARRAY Technologies, Inc. Reports Financial Results for the First Quarter 2025
2025 First Quarter Highlights Revenue of $302.4 million Gross Margin of 25.3% Adjusted gross margin(1) of 26.5% Net income to common shareholders of $2.3 million Adjusted EBITDA(1) of $40.6 million Net income per basic and diluted share of $0.02 Adjusted …

Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients
TPM502 achieved significant and dose-dependent reduction in IL-2 and IFN-γ release by gluten-specific T cells and durable immunomodulation of gluten-specific CD4+ T cells Patient-reported outcomes indicated dose-dependent reduction of symptoms following a …

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025
EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025 EBX-102-02 was well tolerated and demonstrated clinically meaningful improvements across multiple symptom domains in IBS-C patients Ph2b trial in IBS-C initiating in H2 2025 to …

MADD Canada’s Campaign 911 Urges People to Report Suspected Impaired Drivers, Riders and Boaters
OAKVILLE, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- An impaired driver is an emergency. That’s the powerful message at the heart of MADD Canada’s Campaign 911, the national awareness program launching today to encourage Canadians to call 911 and report …

La Campagne 911 de MADD Canada exhorte les gens à signaler les conducteurs d’auto, de VTT et de bateau dont les capacités semblent affaiblies
OAKVILLE, Ontario, 06 mai 2025 (GLOBE NEWSWIRE) -- Les conducteurs aux capacités affaiblies sont des situations d’urgence. C’est le puissant message au cœur de la Campagne 911 de MADD Canada, le programme de sensibilisation nationale, lancé aujourd’hui …

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …

Reminder - Stella-Jones’ First Quarter Results Conference Call and Annual Meeting of Shareholders
MONTRÉAL, May 06, 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ), (“Stella-Jones” or “the Company”) will hold a conference call to discuss its first quarter results: THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE …

Rappel - Téléconférence du premier trimestre et assemblée annuelle des actionnaires de Stella-Jones
MONTRÉAL, 06 mai 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX : SJ) (« Stella-Jones » ou « la Société» tiendra une téléconférence pour discuter des résultats du premier trimestre. OUVERTE AUX : Investisseurs, analystes et autres personnes intéressées …

Lantronix to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025
IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Lantronix CEO Saleel Awsare and CFO Brent Stringham will …

Datadog Announces First Quarter 2025 Financial Results
First quarter revenue grew 25% year-over-year to $762 million Robust growth of larger customers, with about 3,770 $100k+ ARR customers, up from about 3,340 a year ago Announced 2025 DASH user conference, June 10-11, in New York City NEW YORK, May 06, 2025 …